IL17A and relapsing-remitting multiple sclerosis: To determine the serum concentrations of anti- and pro-inflammatory cytokines in RRMS patients, we quantified IL-2, IL-4, IL-6, IL-10, IL-17A, IFN-gamma, and TNF by cytometric bead array.